Pharmaceutical Technology

DECEMBER 5, 2023

Nitric oxide is under clinical development by SaNOtize Research and Development and currently in Phase II for Warts. According to…

Development 100

Development Research Clinical Development 100

Pharmaceutical Technology

DECEMBER 5, 2023

Nitric oxide is under clinical development by SaNOtize Research and Development and currently in Phase II for Warts. According to…

Development 100

Development Research Clinical Development 100

Pharmaceutical Technology

DECEMBER 5, 2023

Nitric oxide is under clinical development by SaNOtize Research and Development and currently in Phase II for Warts. According to…

Development 100

Development Research Clinical Development 100

Pharmaceutical Technology

DECEMBER 5, 2023

Nitric oxide is under clinical development by SaNOtize Research and Development and currently in Phase II for Warts. According to…

Development 100

Development Research Clinical Development 100

Pharmaceutical Technology

DECEMBER 5, 2023

Nitric oxide is under clinical development by SaNOtize Research and Development and currently in Phase II for Warts. According to…

Development 100

Development Research Clinical Development 100

Advarra

OCTOBER 4, 2023

When it comes to clinical development, precision, compliance, and quality assurance are paramount. For clinical development organizations, an effective CAPA serves as an essential compass, directing a path towards continuous improvement while maintaining steadfast regulatory compliance.

Compliance 52

Compliance Clinical Development Development Clinical Trials 52

Pharmaceutical Technology

JANUARY 4, 2024

TBO-309 is under clinical development by Heart Research Institute and currently in Phase II for Acute Ischemic Stroke.

Research 100

Research Clinical Development Development 100

Pharmaceutical Technology

DECEMBER 6, 2023

Nitric oxide is under clinical development by SaNOtize Research and Development and currently in Phase II for Warts.

Development 100

Development Research Clinical Development 100

Pharmaceutical Technology

MAY 12, 2023

The research team has designed four bacterial viruses which use CRISPR technology to kill the unwanted bacteria precisely. The US Food and Drug Administration has granted fast-track designation to SNIPR001, which is currently in clinical development.

Development 246

Development Bacteria Research Gene Editing 246

Medical Xpress

MARCH 23, 2023

Researchers at Texas A&M University have developed the first molecular therapeutic for Angelman syndrome to advance into clinical development.

Development 98

Development Research Clinical Development 98

Pharma Mirror

FEBRUARY 25, 2022

This joint service offering, DRIVE™-Biologics, will leverage Abzena’s strength in design and developability, and cell line development through to commercial manufacturing.

Clinical Development 130

Clinical Development Development Manufacturing Medicine 130

Pharmaceutical Technology

MARCH 20, 2023

Predictive Oncology and Cancer Research Horizons, a part of Cancer Research UK (CRUK), has collaborated to drive cancer drug development using the former’s PEDAL platform. This helps in more informed drug-tumour type combinations selection for clinical development.

Research 130

Research Clinical Development Drugs Development 130

Worldwide Clinical Trials

DECEMBER 7, 2023

Amidst a shifting clinical landscape characterized by increasingly complex trial designs and growing patient subpopulations, many contract research organizations (CROs) have adopted a “one-stop-shop” strategic approach. What Differentiates Mid-Size CROs?

Clinical Development 333

Clinical Development Clinical Trials Clinical Trials Trials 333

Drug Discovery World

MARCH 10, 2023

Cancer Research UK and UCB have agreed a clinical development collaboration to advance two of UCB’s investigational oncology antibody candidates through clinical trials. If successful in clinical trials the investigational candidates may have the potential to offer cancer patients access to new targeted treatment options.

Antibody 98

Antibody Research Clinical Trials Clinical Trials 98

Pharmaceutical Technology

JANUARY 16, 2023

Ono Pharmaceutical and Monash University have entered an option and research collaboration for the discovery and development of antibodies that target G protein-coupled receptors (GPCRs). The post Ono Pharmaceutical enters research deal with Monash University appeared first on Pharmaceutical Technology.

Research 130

Research Antibody Sales Development 130

Pharmaceutical Technology

FEBRUARY 21, 2023

Japanese firm Teijin has announced its basic agreement on a capital and business alliance with Axcelead to establish a drug discovery research joint venture (JV) company. In addition to supporting drug discovery research, the new company will investigate and acquire candidate compounds for new drugs.

Research 130

Research Drugs Clinical Development Development 130

AuroBlog - Aurous Healthcare Clinical Trials blog

JANUARY 16, 2024

Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, and the Japanese Foundation for Cancer Research (JFCR), the first and leading non-profit cancer research organization in Japan, has announced a strategic alliance to accelerate access to oncology clinical (..)

Clinical Trials 152

Clinical Trials Clinical Trials Trials Clinical Research 152

Outsourcing Pharma

APRIL 23, 2024

In a major partnership aimed at accelerating research into Rett syndrome, a rare neurological disorder predominantly affecting girls, digital healthcare solutions company Vivalink, has joined forces with the Rett Syndrome Research Trust (RSRT).

Research 98

Research Clinical Development Development 98

Worldwide Clinical Trials

APRIL 15, 2024

As the clinical research landscape continually evolves, the choice of a Contract Research Organization (CRO) partner can significantly impact the success of drug development programs.

Clinical Trials 130

Clinical Trials Clinical Trials Clinical Development Clinical Research 130

XTalks

FEBRUARY 23, 2024

Chicago-based Linden Capital Partners and Canada’s Ontario Teachers’ Pension Plan are partnering with Elligo Health Research to launch a platform focused on advancing clinical research. This collaboration aims to leverage Elligo’s expertise in healthcare research, utilizing their innovative approaches to clinical trials.

Clinical Research 59

Clinical Research Research Clinical Trials Clinical Trials 59

Outsourcing Pharma

MARCH 24, 2022

The companyâs analysis of clinical research activity in the region shows the conflict will have long-lasting effects that reach beyond the countryâs borders.

Clinical Development 59

Clinical Development Development Clinical Research Research 59

BioPharma Reporter

APRIL 3, 2024

Dr Laura Trotta joined CluePoints in 2015 and moved into her current role as vice president of research in January 2022, where she leads a team of research scientists responsible for developing new statistical and machine learning algorithms to assess the quality of clinical trial data.

Research 104

Research Clinical Trials Clinical Trials Scientist 104

Drug Discovery World

NOVEMBER 6, 2023

Cancer Research UK and the KWF Dutch Cancer Society (KWF) have announced a new multi-project strategic partnership to advance promising therapeutic agents for cancer. Both parties will have the opportunity to identify and nominate potential projects for clinical development. The CDD will sponsor and manage KWF-supported trials.

Research 52

Research Clinical Trials Clinical Trials Clinical Development 52

Drug Discovery World

OCTOBER 24, 2023

The DDW Turning Science into Business Summit, ‘ Cancer research opportunities and advances ’ will take place online on 16 November at 7AM PST / 10AM EDT / 3PM GMT / 4PM CET. This free summit, sponsored by Taconic, will offer expert thought leadership on cancer research, precision medicine and immunotherapy.

Vaccination 52

Vaccination Vaccine Research Clinical Development 52

The Pharma Data

MARCH 23, 2022

Baynes, head of Global Clinical Development (GCD) and Chief Medical Officer, Merck Research Laboratories (MRL), will be retiring from Merck in July. Li, president, Merck Research Laboratories, until his retirement. Li, president, Merck Research Laboratories, until his retirement.

Clinical Development 52

Clinical Development Development Vaccination Vaccine 52

BioTech 365

JULY 13, 2021

Lung Therapeutics Announces Appointment of Sharon Morriss, PhD, as Senior Vice President of Clinical Development Lung Therapeutics Announces Appointment of Sharon Morriss, PhD, as Senior Vice President of Clinical Development Key leadership appointment of Dr. Morriss enhances the company’s research … Continue reading →

Clinical Development 52

Clinical Development Development Research 52

Drug Discovery World

FEBRUARY 28, 2024

Lu Rahman selects some of the year’s interesting and noteworthy advances in cancer research drug discovery and development. As always, a year within cancer drug discovery and development brings with it significant breakthroughs, and 2023 has been no exception. Research into new cancer drugs remain strong.

Development 64

Development Research Drugs Antibody 64

Drug Discovery World

OCTOBER 25, 2023

iOnctura, a clinical-stage biotech developing selective cancer therapies against targets that play critical roles in multiple tumour survival pathways, has published new research data in the peer-reviewed journal Cancer Research, that supports a strategy of combining autotaxin inhibitor IOA-289 with TGF-β pathway inhibitor IOA-359.

Research 52

Research In-Vivo In-Vitro Clinical Development 52

Drug Discovery World

JANUARY 23, 2024

These high levels of attrition at Phase II may slow the rate at which new therapies reach market and are likely to have an ongoing effect on the clinical development industry, adding to rising costs. The post Breast cancer most researched disease area for third year running appeared first on Drug Discovery World (DDW).

Research 52

Research Clinical Trials Clinical Trials Trials 52

Velocity Clinical Research

OCTOBER 4, 2023

Velocity Clinical Research, the leading multi-specialty clinical sites business, announced it is opening greenfield clinical research sites in Bristol, Leicester, and Romford, demonstrating the company’s commitment to the U.K. The sites launch at a time when clinical trial activity in the U.K.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

pharmaphorum

MARCH 17, 2021

Hopes that the UK government would step in to support charity-funded medical research were dashed when the sector received no mention in the Budget despite campaigns to secure additional support. So, when research is at risk, what are the potential consequences for patient care, the wider research community, and UK plc in general?

Research 95

Research Development Life Science Clinical Development 95

Outsourcing Pharma

AUGUST 5, 2021

A leader from the clinical research tech specialist explains how the use of AI is increasing in the field and outlines the many ways it could SOMETHING.

Research 145

Research Clinical Research Clinical Development Development 145

Outsourcing Pharma

AUGUST 3, 2021

The Psychae Institute, established by a global team of scientists, will conduct pre-clinical and clinical research around psychedelic medicine development.

Research 130

Research Scientist Clinical Research Medicine 130

Fierce Pharma

FEBRUARY 20, 2024

This week on “The Top Line,” we’re speaking with Jared Baeten, MD, PhD, Vice President, HIV Clinical Development, Gilead Sciences about how advancements in HIV treatment research have enabled indiv | This week, we’re speaking with Jared Baeten, MD, PhD, Vice President, HIV Clinical Development, Gilead Sciences about how advancements in HIV treatment (..)

Clinical Development 61

Clinical Development Development Research 61

Drug Discovery World

JULY 19, 2023

We are developing satoreotide as a ‘theranostic’ pair for the combined diagnosis and targeted radionuclide treatment. Through our partnership with UCB Pharma, we explore additional new targets to develop first-in-class radiopharmaceuticals to continue expanding our pipeline beyond the two lead assets.

Research 52

Research Development Production Clinical Development 52

Scienmag

APRIL 19, 2021

Credit: Molecular Therapy – Methods and Clinical Development A joint research carried out by MIPT scientists and Harvard researchers have presented retinal cells that can integrate into the retina.

Research 63

Research Scientist Clinical Development Development 63

Outsourcing Pharma

APRIL 29, 2024

A significant milestone has been reached by Olden Labs as it steps into the limelight revealing its refreshing approach to animal research.

Research 52

Research Clinical Development Development 52